Recent News

By Category: Research

New Sensor Could Detect Quickly Viral Bioterror Agents

Scientists at Boston University have developed a biological sensor that could be used to rapidly detect a wide range of viral pathogens including the lethal Ebola and Marburg viruses, the institution announced last week. As with other viruses that produce symptoms not necessarily indicative of viral infection, Marburg and Ebola outbreaks can be challenging to Read More »

November 24, 2010
| Filed under North America, Biotechnology, Countermeasures, and Research
Share

Soligenix Announces Issuance Of United States Patent For RiVax™, Its Vaccine Against Ricin Toxin

Soligenix, Inc. (OTC Bulletin Board: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company, announced today that the United States Patent and Trademark Office (USPTO) has granted patent #7,829,668, entitled “Compositions and methods for modifying toxic effects of proteinaceous compounds…

November 23, 2010
| Filed under North America, Countermeasures, and Research
Share

New tool detects Ebola, Marburg quickly, easily

(Boston University College of Engineering) Boston University researchers have developed a simple diagnostic tool that can quickly identify dangerous viruses like Ebola and Marburg. The biosensor, which is the size of a quarter and can detect viruses in a blood sample, could be used in developing nations, airports and other places where natural or man-made Read More »

November 22, 2010
| Filed under North America, Biotechnology, and Research
Share

Scientists Identify Antivirus System

Viruses that cause disease in animals beat the security system millennia ago. But now that researchers are aware of it, they can explore the possibility of bringing the system back into play in the fight against diseases such as sudden acute respiratory syndrome (SARS), West Nile virus, dengue and yellow fever…

November 18, 2010
| Filed under North America and Research
Share

NIH Awards $10 Million For Microneedle Vaccine Patch

The National Institutes of Health (NIH) has awarded $10 million to the Georgia Institute of Technology, Emory University and PATH, a Seattle-based nonprofit organization, to advance a technology for the painless, self-administration of flu vaccine using patches containing tiny microneedles that dissolve into the skin…